Related Experiment Video
Updated: May 15, 2025

A Pleural Effusion Model in Rats by Intratracheal Instillation of Polyacrylate/Nanosilica
Published on: April 12, 2019
Pleural Fluid Biomarkers of Pediatric Parapneumonic Effusion
Jose D Santotoribio1,2,3, David Nuñez-Jurado4, Jose L Rubio-Prieto4
1Department of Laboratory Medicine, Puerto Real University Hospital, 11510 Cadiz, Spain.
Insights
Pediatric parapneumonic pleural effusion (PPE) shows age-specific differences in pleural fluid biomarkers. Infants have higher glucose and lower protein, while children exhibit a more acute inflammatory response.
Area of Science:
- Pediatric Pulmonology
- Infectious Diseases
- Biomarker Research
Background:
- Parapneumonic pleural effusion (PPE) is a common complication of community-acquired pneumonia in children.
- Understanding age-related differences in PPE is crucial for accurate diagnosis and management.
Purpose of the Study:
- To analyze pleural fluid characteristics in pediatric patients with PPE.
- To compare pleural fluid biomarkers between infants and older children.
- To assess correlations between age and specific biomarkers.
Main Methods:
- Analysis of pleural fluid from 54 pediatric patients (14 infants, 40 children) with PPE.
- Measurement of white blood cell (WBC) count, glucose, total protein, lactate dehydrogenase (LDH), adenosine deaminase (ADA), and pH.
- Statistical assessment of age-group differences and age-biomarker correlations.
Main Results:
- Pediatric PPE typically presents as exudate with high WBC, protein, and LDH.
- Infants showed more mononuclear WBC, higher glucose, and lower protein than children.
- Age correlated positively with polymorphonuclear WBC and protein, and negatively with glucose.
Conclusions:
- Significant age-specific variations in pleural fluid biomarkers exist in pediatric PPE.
- Children may mount a more acute inflammatory response than infants.
- Age-related differences are important for diagnosing and managing pediatric PPE.
Abstract:
Background/Objectives: Parapneumonic pleural effusion (PPE) secondary to community-acquired pneumonia is the most common cause of pediatric pleural effusion. This study aimed to evaluate the pleural fluid characteristics of pediatric patients with PPE and to compare biomarkers between infants (1-12 months) and children (1-14 years). Methods: Fifty-four pediatric patients (14 infants and 40 children) with PPE were included. Pleural fluid samples were analyzed for white blood cell (WBC) count, glucose, total protein, lactate dehydrogenase (LDH), adenosine deaminase (ADA), and pH levels. Differences between age groups and correlations between age and pleural fluid biomarkers were assessed. Results: Most pediatric PPE cases exhibited biochemical characteristics consistent with pleural exudate: WBC > 1000 cells/µL, total protein > 3 g/dL, LDH > 200 U/L. Infants showed a predominance of mononuclear WBC, while children exhibited a predominance of polymorphonuclear WBC. Glucose levels were higher, and total protein levels were lower in infants compared to children. Age was positively correlated with polymorphonuclear WBC percentage (rho = 0.509, p < 0.001) and protein levels (rho = 0.622, p < 0.001), whereas glucose levels were negatively correlated with age (rho = -0.274, p = 0.043). Conclusions: Age-specific differences in pleural fluid biomarkers were observed in pediatric patients with PPE, suggesting a more robust and acute inflammatory response in children compared to infants. These findings underscore the importance of considering age-related variations in the inflammatory response when diagnosing and managing PPE in pediatric populations.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumonia III: Complications and Assessment
Respiratory System Abnormal Finding II: Palpation and Auscultation
Palpation Findings
During a respiratory assessment, palpation can reveal several vital abnormalities:
Physical Assessment of the Respiratory Tract II: Palpation
Thoracic Palpation
Thoracic palpation detects tenderness, masses, lesions, respiratory excursions, and vocal fremitus. The nurse assesses...
Pneumonia II: Pathophysiology

